InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Tuesday, 03/30/2021 10:17:15 PM

Tuesday, March 30, 2021 10:17:15 PM

Post# of 42820
Lenzilumab is about to become the drug of choice for all severe patients around the world. They need to massively increase production. That costs money. I know people will say they that had all of that secured. But things weren't really going to get ramped up until an EUA or at least good data.

Here is an article from March 10th talking about Thermo Fisher adding $600 million in facilities to meet Covid demand. Humanigen is talked about at the bottom.
https://www.fiercepharma.com/manufacturing/thermo-fisher-lays-out-600m-to-more-than-double-capacity-for-biologics-and-vaccines